Description
CJC-1295 with DAC is a modified analogue of growth hormone-releasing hormone commonly examined in laboratory peptide research involving GH and IGF-1 signalling pathways. The DAC component is designed to extend peptide activity in controlled research settings, making CJC-1295 with DAC a widely discussed compound in endocrine pathway investigation, long-acting peptide research, and hormone signalling studies.






Reviews
There are no reviews yet.